Portfolio Companies News
February 18, 2019Oncopeptides will host a webcast in...
Stockholm —18 February 2019 — Oncopeptides AB (Nasdaq Stockholm, ONCO) today announces that the Company will release its Year-end Report on 22 February at 8:00 am CET. The report will be available on the Company’s web site at www.oncopeptides.com. The company’s CEO Jakob Lindbe... read more
February 15, 2019Rainier Therapeutics Presents Data ...
– Preliminary data from FIERCE-21 Phase 2 trial highlighted in oral presentation supports advancement to pivotal study – – Single agent activity and long-term treatment duration demonstrated– SAN LEANDRO, Calif., February 15, 2019—Rainier Therapeutics, Inc., a privately-held clinical s... read more
February 14, 2019Targovax ASA: Fourth quarter and fu...
Thursday, February 14, 2019 Oslo, Norway, 14 February 2019 - Targovax ASA (OSE: TRVX), a clinical stage biotechnology company developing immune activators to target hard-to-treat solid tumors, today announces its fourth quarter and full year 2018 results. A meeting for investors, analysts ... read more
February 14, 2019MIPS - Year end report 2018
THU, FEB 14, 2019 07:30 CET OCT - DEC Net sales increased by 53% to SEK 62.2m (40.6). Adjusted for currency exchange rate effects, the increase was 44% Operating profit increased to SEK 28.7m (14.6). Operating profit includes litigation costs of SEK 0.1m (4.1) relating to the company... read more
February 13, 2019Vicore Pharma postpones publication...
Mölndal, February 13, 2019 - Vicore Pharma Holding AB (publ) has decided to postpone the publication of the year-end report for 2018. The year-end report will be published on March 15, 2019, instead of previously announced February 22, 2019. The reason for postponing the report is the decision ... read more
February 18, 2019Q4 2018 General Market Overview
Since the start in 1996, HealthCap funds have invested in 113 portfolio companies.
42 of the portfolio companies have been taken public on nine different markets.
25 of the portfolio companies’ pharmaceutical products have been approved for marketing.
Since the start in 1996, HealthCap has helped build 7 companies with a valuation of USD 1 billion or more and 35 companies with a valuation of SEK 1 billion or more.